Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor

Clinical trial NCT04810091 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04810091
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced Neuroendocrine Neoplasm Metastatic Neuroendocrine Neoplasm

Start date: 2021-05-18
Primary completion: 2025-08-31
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.